Ant Capital Partners logo

Ant Capital Partners

Asia, Tokyo, Japan, Tokyo

Description

Ant Capital Partners is a private equity and venture capital firm that focuses on investing in small and middle-market Japanese companies.

Investor Profile

Ant Capital Partners has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series C (25%)
  • Seed (25%)
  • Series Unknown (25%)
  • Series A (25%)

Country Focus

  • Japan (50%)
  • United States (25%)
  • United Kingdom (25%)

Industry Focus

  • Internet Of Things
  • Saas
  • Software
  • Biopharma
  • Biotechnology
  • Health Diagnostics
  • Alternative Medicine
  • Health Care
  • Market Research
  • Messaging
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ant Capital Partners frequently co-invest with?

Mitsui & Co
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Acorn Pacific Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
Black River Ventures
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
SAIF Partners
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Cisco Investments
North America, California, United States, San Francisco
Co-Investments: 1
IFC Venture Capital Group
North America, District of Columbia, United States, Washington
Co-Investments: 1
Crosslink Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Linear Venture
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Oriza Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
SJF Ventures
North America, North Carolina, United States, Durham
Co-Investments: 1

What are some of recent deals done by Ant Capital Partners?

Ayla Networks

Milpitas, California, United States

Ayla Networks' Internet of Things (IoT) platform-as-a-service (PaaS) delivers industry-leading device management and application enablement.

Internet of ThingsSaaSSoftware
Series CJun 27, 2016
Amount Raised: $39,000,000
XConnect Global Networks

London, England, United Kingdom

XConnect provides interconnection services driving the adoption of IP-based multimedia communications.

MessagingTelecommunicationsVideoVoIP
Series AApr 24, 2007
Amount Raised: $12,000,000
REGiMMUNE

Tokyo, Tokyo, Japan

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

BiopharmaBiotechnologyHealth Diagnostics
SeedAug 15, 2006
Amount Raised: $1,600,000
CellSeed

Tokyo, Tokyo, Japan

CellSeed develops regenerative medicine products primarily in Japan and Europe.

Alternative MedicineHealth CareMarket Research
Series UnknownNov 2, 2005
Amount Raised: $7,000,435